Cases & Deals

  • Home
  • Practices
  • ADOCIA initiates Level I ADR program in United States

Share

ADOCIA initiates Level I ADR program in United States

May 2014

Client(s) ADOCIA

Jones Day advised ADOCIA, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, in connection with the implementation of its Level I American Depositary Receipt Program for the U.S. market with the Bank of New York Mellon on the OTC Markets.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.